Thermo Fisher's PPD business signs enterprise RWD agreement with HealthVerity

What happened

• Announced April 13, 2026 in Applied Clinical Trials, citing a Thermo Fisher news release the same day.
• PPD gains enterprise-level access to HealthVerity's taXonomy claims dataset covering more than 270 million de-identified patient lives across the US healthcare system.
• The agreement also provides access to a marketplace of more than 70 curated data sources, including electronic medical records, laboratory results, and specialty datasets.
• PPD intends to use the data across trial feasibility, site selection, patient recruitment, and RWE generation, including PPD CorEvitas Clinical Registries and PPD Evidera solutions.
• Krishna Cheriath, vice president and head of clinical research digital and AI at Thermo Fisher Scientific, and Joseph Satili, chief commercial officer at HealthVerity, provided statements on the collaboration.
• Follows a February 11, 2026 PPD collaboration with Datavant integrating tokenization across RCTs, PPD CorEvitas Clinical Registries, and PPD Evidera, over a Datavant ecosystem of more than 350 real-world data partners and approximately 80,000 US hospitals and clinics.

Who is involved

Sources

1. appliedclinicaltrialsonline.com — primary